Association of HLA-DRB1 Alleles with Rheumatic Fever and Rheumatic Heart Disease: A Meta-analysis

References

• Auckland K, Mittal B, Cairns BJ, et al. 2019. The human leukocyte antigen locus and susceptibility to rheumatic heart disease in South Asians and Europeans. medRxiv. 19003160.
   Google Scholar
• Ayoub EM, Barrett DJ, Maclaren NK, Krischer JP. 1986. Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest. 77(6):2019–26.
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics. 50(4):1088–101.
   PubMed Web of Science ®Google Scholar
• Bhatt M, Kumar S, Siddiqui MH, Garg N, Mittal B. 2018. Influence of cytokine gene polymorphism on the risk of rheumatic heart disease–A meta-analysis. Immunol Lett. 194:69–78.
   PubMed Web of Science ®Google Scholar
• Carapetis JR, Beaton A, Cunningham MW, Guilherme L, Karthikeyan G, Mayosi BM, Sable C, Steer A, Wilson N, Wyber R, Zühlke L. 2016. Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Primers. 2:15084.
   PubMed Web of Science ®Google Scholar
• Cunningham MW. 2014. Rheumatic fever, autoimmunity, and molecular mimicry: the streptococcal connection. Int Rev Immunol. 33(4):314–29.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. 1986. Meta-analysis in clinical trials. Control Clin Trials. 7(3):177–88.
   PubMedGoogle Scholar
• Egger M, Smith GD, Schneider M, Minder C. 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ. 315(7109):629–34.
   PubMed Web of Science ®Google Scholar
• El-Hagrassy N, El-Chennawi F, Zaki Mel S, Fawzy H, Zaki A, Joseph N. 2010. HLA class I and class II HLA DRB profiles in Egyptian children with rheumatic valvular disease. Pediatr Cardiol. 31(5):650–56.
   PubMed Web of Science ®Google Scholar
• Gray LA, D’Antoine HA, Tong SYC, McKinnon M, Bessarab D, Brown N, Reményi B, Steer A, Syn G, Blackwell JM, et al. 2017. Genome-wide analysis of genetic risk factors for rheumatic heart disease in Aboriginal Australians provides supportfor pathogenic molecular mimicry. J Infect Dis. 216(11):1460–70.
   PubMed Web of Science ®Google Scholar
• Guédez Y, Kotby A, El-Demellawy M, Galal A, Thomson G, Zaher S, Kassem S, Kotb M. 1999. HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogeneous patients. Circulation. 99(21):2784–90.
   PubMed Web of Science ®Google Scholar
• Guilherme L, Kalil J, Cunningham M. 2006. Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity. 39(1):31–39.
   PubMed Web of Science ®Google Scholar
• Guilherme L, Weidebach W, Kiss MH, Snitcowsky R, Kalil J. 1991. Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population. Circulation. 83(6):1995–98.
   PubMed Web of Science ®Google Scholar
• Gündogdu F, Islamoglu Y, Pirim I, Gurlertop Y, Dogan H, Arslan S, Sevimli S, Aksakal E, Senocak H. 2007. Human leukocyte antigen (HLA) class I and II alleles in Turkish patients with rheumatic heart disease. J Heart Valve Dis. 16(3):293–99.
   PubMed Web of Science ®Google Scholar
• Hajjej A, Almawi WY, Stayoussef M, Arnaiz-Villena A, Hattab L, Hmida S. 2019. Association of HLA-DRB1 and-DQB1 alleles with type 1 (autoimmune) diabetes in African Arabs: systematic review and meta-analysis. Immunol Invest. 48(2):130–46.
   PubMed Web of Science ®Google Scholar
• Hallioglu O, Mesci L, Ozer S. 2005. DRB1, DQA1, DQB1 genes in Turkish children with rheumatic fever. Clin Exp Rheumatol. 23(1):117–20.
   PubMed Web of Science ®Google Scholar
• Haydardedeoglu FE, Tutkak H, Kose K, Duzgun N. 2006. Genetic susceptibility to rheumatic heart disease and streptococcal pharyngitis: association with HLA-DR alleles. Tissue Antigens. 68(4):293–96.
   PubMedGoogle Scholar
• Hernández-Pacheco G, Aguilar-García J, Flores-Domínguez C, Rodrı́guez-Pérez JM, Pérez-Hernández N, Alvarez-Leon E, Reyes PA, Vargas-Alarcón G. 2003. MHC class II alleles in Mexican patients with rheumatic heart disease. Int J Cardiol. 92(1):49–54.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. 2002. Quantifying heterogeneity in a meta-analysis. Stat Med. 21(11):1539–58.
   PubMed Web of Science ®Google Scholar
• Jhinghan B, Mehra NK, Reddy KS, Taneja V, Vaidya MC, Bhatia ML. 1986. HLA, blood groups and secretor status in patients with established rheumatic fever and rheumatic heart disease. Tissue Antigens. 27(3):172–78.
   PubMedGoogle Scholar
• Koyanagi T, Koga Y, Nishi H, Toshima H, Sasazuki T, Imaizumi T, Kimura A. 1996. DNA typing of HLA class II genes in Japanese patients with rheumatic heart disease. J Mol Cell Cardiol. 28(6):1349–53.
   PubMed Web of Science ®Google Scholar
• Kudat H, Telci G, Sozen AB, Oguz F, Akkaya V, Ozcan M, Atilgan D, Carin M, Guven O. 2006. The role of HLA molecules in susceptibility to chronic rheumatic heart disease. Int J Immunogenet. 33(1):41–44.
   PubMed Web of Science ®Google Scholar
• Liang Y, Yang Z, Zhong R. 2012. Primary biliary cirrhosis and cancer risk: a systematic review and meta-analysis. Hepatology. 56(4):1409–17.
   PubMed Web of Science ®Google Scholar
• Macleod CK, Bright P, Steer AC, Kim J, Mabey D, Parks T. 2019. Neglecting the neglected: the objective evidence of underfunding in rheumatic heart disease. Trans R Soc Trop Med Hyg. 113(5):287–90.
   PubMed Web of Science ®Google Scholar
• Mantel N, Haenszel W. 1959. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 22(4):719–48.
   PubMed Web of Science ®Google Scholar
• Martin WJ, Steer AC, Smeesters PR, Keeble J, Inouye M, Carapetis J, Wicks IP. 2015. Post-infectious group A streptococcal autoimmune syndromes and the heart. Autoimmun Rev. 14(8):710–25.
   PubMed Web of Science ®Google Scholar
• Matzaraki V, Kumar V, Wijmenga C, Zhernakova A. 2017. The MHC locus and genetic susceptibility to autoimmune and infectious diseases. Genome Biol. 18(1):76.
   PubMedGoogle Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma Group. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6(7):e1000097.
   PubMed Web of Science ®Google Scholar
• Muhamed B, Parks T, Sliwa K. 2019. Genetics of rheumatic fever and rheumatic heart disease. Nat Rev Cardiol. 17(3):145–154.
   PubMed Web of Science ®Google Scholar
• Okello E, Beaton A, Mondo CK, Kruszka P, Kiwanuka N, Odoi-Adome R, Freers J. 2014. Rheumatic heart disease in Uganda: the association between MHC class II HLA DR alleles and disease: a case control study. BMC Cardiovasc Disord. 14(1):28.
   PubMedGoogle Scholar
• Ozkan M, Carin M, Sonmez G, Senocak M, Ozdemir M, Yakut C. 1993. HLA antigens in Turkish race with rheumatic heart disease. Circulation. 87(6):1974–78.
   PubMed Web of Science ®Google Scholar
• Poomarimuthu M, Elango S, Solomon PR, Soundrapandian S, Mariakuttikan J. 2018. Association of IL17 and IL23R gene polymorphisms with rheumatic heart disease in South Indian population. Immunol Invest. 47(7):754–64.
   PubMed Web of Science ®Google Scholar
• Reddy KS, Narula J, Bhatia R, Shailendri K, Koicha M, Taneja V, Jhingan B, Pothineni RB, Malaviya AN, Mehra NK, Vaidya MC. 1990. Immunologic and immunogenetic studies in rheumatic fever and rheumatic heart disease. Indian J Pediatr. 57(5):693–700.
   PubMedGoogle Scholar
• Rehman S, Akhtar N, Ahmad W, Ayub Q, Mehdi SQ, Mohyuddin A. 2007. Human leukocyte antigen (HLA) class II association with rheumatic heart disease in Pakistan. J Heart Valve Dis. 16(3):300–04.
   PubMed Web of Science ®Google Scholar
• Shiina T, Hosomichi K, Inoko H, Kulski JK. 2009. The HLA genomic loci map: expression, interaction, diversity and disease. J Hum Genet. 54(1):15–39.
   PubMed Web of Science ®Google Scholar
• Simonini G, Porfirio B, Cimaz R, Calabri GB, Giani T, Falcini F. 2004. Lack of association between the HLA-DRB1 locus and post-streptococcal reactive arthritis and acute rheumatic fever in Italian children. Semin Arthritis Rheum. 34(2):553–58.
   PubMed Web of Science ®Google Scholar
• Sreekanth MS, Basha SE, Kumar GA, Govindaraju S, Nayar NP, Pitchappan RM. 2016. Association of IL-1β+ 3953 C and HLA-DRB1*15 with coronary artery and rheumatic heart diseases in South India. Hum Immunol. 77(12):1275–79.
   PubMed Web of Science ®Google Scholar
• Stanevicha V, Eglite J, Sochnevs A, Gardovska D, Zavadska D, Shantere R. 2003. HLA class II associations with rheumatic heart disease among clinically homogeneous patients in children in Latvia. Arthritis Res Ther. 5(6):R340–6.
   PubMed Web of Science ®Google Scholar
• Taneja V, Mehra NK, Reddy KS, Narula J, Tandon R, Vaidya MC, Bhatia ML. 1989. HLA-DR/DQ antigens and reactivity to B cell alloantigen D8/17 in Indian patients with rheumatic heart disease. Circulation. 80(2):335–40.
   PubMed Web of Science ®Google Scholar
• Toor D, Leal K, Kumar R, Sharma YP, Chakraborti A. 2012. Association of HLA-DRB1*14 with rheumatic heart disease patients from Chandigarh, North India. Biomarkers. 17(2):160–65.
   PubMed Web of Science ®Google Scholar
• Visentainer JE, Pereira FC, Dalalio MM, Tsuneto LT, Donadio PR, Moliterno RA. 2000. Association of HLA-DR7 with rheumatic fever in the Brazilian population. J Rheumatol. 27(6):1518–20.
   PubMed Web of Science ®Google Scholar
• Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A, Bukhman G, Forouzanfar MH., Longenecker CT, Mayosi BM, Mensah, GA. and Nascimento BR. 2017. Global, regional, and national burden of rheumatic heart disease, 1990–2015. N Engl J Med. 377(8):713–22.
   PubMed Web of Science ®Google Scholar
• Wells GA, Shea B, O’connell D, Peterson J, Welch V, Losos M, Tugwell P. 2012. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford. asp.
   Google Scholar